RecruitingNCT06928337
Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality.
CHLOE Oocyte Data Collection Protocol
Sponsor
Fairtility
Enrollment
350 participants
Start Date
May 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This data collection protocol is aimed to allow the reliable and robust development (training, verification, and validations) of CHLOE technology-based applications as well as improve the machine learning stage of released devices/applications. Additionally, a simulated use assessments will be conducted to ensure the correct and easy use of the CHLOE applications.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria2
- Women at least 18 years of age.
- Embryos or eggs cultured in a time-lapse incubator connected to CHLOE Embryo Viewer.
Exclusion Criteria1
- Women with autologous eggs
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEAI evaluation of oocytes.
AI evaluation of oocytes inside a time-lapse incubator.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06928337
Related Trials
Biomarkers of Endometrial Receptivity
NCT046195243 locations
Effect of a Probiotic on the Female Genital Tract Microbiota of Participants With Fertility Disorders.
NCT061222072 locations
Cryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With Cancer
NCT060635511 location
Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model
NCT070179721 location
Menopur And Rekovelle Combination Study Version 2.0
NCT069979002 locations